Principle of the Assay
The microtiter plate provided in this kit has been pre-coated with an antibody specific to a1AGP. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific to a1AGP. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After the TMB substrate solution is added, only those wells that contain a1AGP, biotin-conjugated antibody, and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution, and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of a1AGP in the samples is then determined by comparing the O.D. of the samples to the standard curve.
For Use with serum, plasma, and cell culture supernatants. For Research Use Only. Not for use in diagnostic procedures.
Functions as transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain (By similarity). Appears to function in modulating the activity of the immune system during the acute-phase reaction (By similarity).
AGP1; a1-AGP; ORM1; OMD 1; Orosomucoid 1
|Kit Components||96 Wells Quantity/Size|
|Pre-coated, ready-to-use 96-well strip plate||1 plate|
|Plate sealer for 96 wells||2|
|Diluent buffer||1 bottle|
|Detection Reagent A||1 bottle|
|Detection Reagent B||1 bottle|
|TMB Substrate||1 tube|
|Stop Solution||1 tube|
|Wash Buffer (30 ℅ concentrate)||1 tube|
|Product data sheet||1 copy|
|Storage||The TMB Substrate, Wash Buffer (30X concentrate), and the Stop Solution should be stored at 4°C upon receipt, while the other items should be stored at -20°C.|
Intra-assay Precision (Precision within an assay): 3 samples with low, middle, and high-level a1AGP were tested 20 times on one plate, respectively.
|SENSITIVITY||The minimum detectable dose was 5.5ng/mL.|
|SPECIFICITY||This assay has high sensitivity and excellent specificity for the detection of a1AGP.
No significant cross-reactivity or interference between a1AGP and analogs was observed.
Limited by current skills and knowledge, it is impossible to perform all possible cross-reactivity detection tests between a1AGP and all analogs, therefore, cross reactivity may still exist.